mARC1 Is the Main Contributor to Metabolic Reduction of N-Hydroxyurea
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Medicinal Chemistry"
DOI: 10.1021/acs.jmedchem.4c01148
Abstract: N-Hydroxyurea has been known since the 1960s as an antiproliferative drug and is used both in oncology and for treatment of hematological disorders such as sickle cell anemia where very high daily doses are administered.… read more here.
Keywords: hydroxyurea; contributor metabolic; reduction; main contributor ... See more keywords